172 related articles for article (PubMed ID: 28804570)
1. Value of quality of life analysis in liver cancer: A clinician's perspective.
Li L; Yeo W
World J Hepatol; 2017 Jul; 9(20):867-883. PubMed ID: 28804570
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
[TBL] [Abstract][Full Text] [Related]
3. Correlations of health-related quality of life with serum inflammatory indicators IL-8 and mIBI in patients with hepatocellular carcinoma.
Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AKC; Tang NLS; Lee KF; Lai PBS; Yu SCH; Yeo W
Cancer Manag Res; 2019; 11():2719-2727. PubMed ID: 31040713
[TBL] [Abstract][Full Text] [Related]
4. The association of liver function and quality of life of patients with liver cancer.
Li L; Mo F; Hui EP; Chan SL; Koh J; Tang NLS; Yu SCH; Yeo W
BMC Gastroenterol; 2019 May; 19(1):66. PubMed ID: 31046687
[TBL] [Abstract][Full Text] [Related]
5. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients.
Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AK; Tang NL; Chu CM; Hui J; Lee KF; Yu S; Yeo W
Qual Life Res; 2019 Sep; 28(9):2597-2607. PubMed ID: 31037590
[TBL] [Abstract][Full Text] [Related]
6. Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non-Melanoma Skin Cancer.
Chernyshov PV; Lallas A; Tomas-Aragones L; Arenbergerova M; Samimi M; Manolache L; Svensson A; Marron SE; Sampogna F; Spillekom-vanKoulil S; Bewley A; Forsea AM; Jemec GB; Szepietowski JC; Augustin M; Finlay AY
J Eur Acad Dermatol Venereol; 2019 May; 33(5):816-827. PubMed ID: 30963614
[TBL] [Abstract][Full Text] [Related]
7. Assessing whether EORTC QLQ-30 and FACT-G measure the same constructs of quality of life in patients with total laryngectomy.
Iravani K; Jafari P; Akhlaghi A; Khademi B
Health Qual Life Outcomes; 2018 Sep; 16(1):183. PubMed ID: 30217200
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and hepatocellular carcinoma.
Gandhi S; Khubchandani S; Iyer R
J Gastrointest Oncol; 2014 Aug; 5(4):296-317. PubMed ID: 25083303
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
[TBL] [Abstract][Full Text] [Related]
10. EORTC QLQ-C30 and FACT-Lym for the assessment of health-related quality of life of newly diagnosed lymphoma patients undergoing chemotherapy.
Georgakopoulos A; Kontodimopoulos N; Chatziioannou S; Niakas D
Eur J Oncol Nurs; 2013 Dec; 17(6):849-55. PubMed ID: 23850411
[TBL] [Abstract][Full Text] [Related]
11. Assessing health-related quality of life in gynecologic oncology: a systematic review of questionnaires and their ability to detect clinically important differences and change.
Luckett T; King M; Butow P; Friedlander M; Paris T
Int J Gynecol Cancer; 2010 May; 20(4):664-84. PubMed ID: 20442592
[TBL] [Abstract][Full Text] [Related]
12. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
Li Q; Lin Y; Qiu Y; Gao B; Xu Y
Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
[TBL] [Abstract][Full Text] [Related]
13. Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma.
Gough N; Koffman J; Ross JR; Riley J; Judson I
PLoS One; 2019; 14(9):e0210731. PubMed ID: 31557183
[TBL] [Abstract][Full Text] [Related]
14. A Prospective Evaluation of the Reliability and Utility of Quality of Life Measures in Patients With Hepatocellular Carcinoma.
Kim GA; Kim HI; Chang S; An J; Lee D; Lee HC; Han S; Shim JH
Am J Clin Oncol; 2019 Jul; 42(7):555-563. PubMed ID: 31135382
[TBL] [Abstract][Full Text] [Related]
15. Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients.
Beisland E; Aarstad HJ; Aarstad AK; Bakke A; Bostad L; Beisland C
Acta Oncol; 2016; 55(3):349-56. PubMed ID: 26251300
[TBL] [Abstract][Full Text] [Related]
16. Quality of life after palliative treatment for oesophageal carcinoma -- a prospective comparison between stent placement and single dose brachytherapy.
Homs MY; Essink-Bot ML; Borsboom GJ; Steyerberg EW; Siersema PD;
Eur J Cancer; 2004 Aug; 40(12):1862-71. PubMed ID: 15288288
[TBL] [Abstract][Full Text] [Related]
17. Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients.
Grande GE; Farquhar MC; Barclay SI; Todd CJ
Palliat Support Care; 2009 Sep; 7(3):289-97. PubMed ID: 19788770
[TBL] [Abstract][Full Text] [Related]
18. Reporting of health-related quality of life (HRQOL) data in oncology trials: a comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACT-G).
Smith AB; Cocks K; Parry D; Taylor M
Qual Life Res; 2014 Apr; 23(3):971-6. PubMed ID: 24097080
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
Grob JJ; Amonkar MM; Karaszewska B; Schachter J; Dummer R; Mackiewicz A; Stroyakovskiy D; Drucis K; Grange F; Chiarion-Sileni V; Rutkowski P; Lichinitser M; Levchenko E; Wolter P; Hauschild A; Long GV; Nathan P; Ribas A; Flaherty K; Sun P; Legos JJ; McDowell DO; Mookerjee B; Schadendorf D; Robert C
Lancet Oncol; 2015 Oct; 16(13):1389-98. PubMed ID: 26433819
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240.
Ryoo BY; Merle P; Kulkarni AS; Cheng AL; Bouattour M; Lim HY; Breder V; Edeline J; Chao Y; Ogasawara S; Yau T; Garrido M; Chan SL; Daniele B; Norquist JM; Chen E; Siegel AB; Zhu AX; Finn RS; Kudo M
Cancer; 2021 Mar; 127(6):865-874. PubMed ID: 33231873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
